Personalis, Inc. Common Stock

PSNLNASDAQUSD
6.58 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
6.59
0.02 (0.23%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
6.59
0.02 (0.23%)
🟢Market: OPEN
Open?$6.61
High?$6.75
Low?$6.51
Prev. Close?$6.58
Volume?700.7K
Avg. Volume?1.6M
VWAP?$6.61
Rel. Volume?0.43x
Bid / Ask
Bid?$5.60 × 100
Ask?$7.43 × 100
Spread?$1.83
Midpoint?$6.52
Valuation & Ratios
Market Cap?688.5M
Shares Out?104.7M
Float?43.6M
Float %?49.2%
P/E Ratio?N/A
P/B Ratio?2.64
EPS?-$0.78
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.76Strong
Quick Ratio?6.61Strong
Cash Ratio?3.14Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
2.64CHEAP
P/S?
9.89HIGH
P/FCF?
N/A
EV/EBITDA?
-7.2CHEAP
EV/Sales?
8.10HIGH
Returns & Efficiency
ROE?
-31.1%WEAK
ROA?
-24.3%WEAK
Cash Flow & Enterprise
FCF?$-79450000
Enterprise Value?$564.2M
Related Companies
Loading...
News
Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Employees
260
Market Cap
688.5M
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2019-06-20
Address
6600 DUMBARTON CIRCLE
FREMONT, CA 94555
Phone: 650-752-1300